Eloxx Pharmaceuticals, Inc.

US$12.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ELOXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (47.14%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (169,223)
PE TTM —
TSR TTM 1131838.13%
Mkt cap US$50.21M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
29.58%
37.66%
Hold 1|7|1|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.33
0.34
0.37
0.38
28.61%
25.05%
19.71%
20.22%
Revenue$M
6.678
6.487
6.330
6.174
13.22%
4.55%
2.46%
(4.22%)
Peers (US$50.21M)
Cap (US$)
PE
51.00M
—
50.25M
—
Capital
TTM
5Y
10Y
Leveragex
0.552
0.821
0.720
EBIT/Intx
0.495
0.681
0.707
Own earn%
31.05
(46.20)
(27.74)
Sh yield%
52.53
13.54
15.23
Owners
Insiders/Inst%
12.68
32.05
Short interest%
1.12
SBC / revenue%
5.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
24–32
$1 testx
0.0
Incr. ROIC%
0